SPRO (Spero Pharma) Earnings per share growth rate in current year

Official company branding of Spero Therapeutics (SPRO)

Spero Therapeutics (SPRO) is expanding its medical center reach by implementing modern oral antibiotics. The current YoY EPS growth rate demonstrates earnings per share dynamics, where the current metric is -721.10. The company utilizes synthesis automation and AI-driven drug design, although testing remains the responsibility of physicians. Demand for therapy is independent of economic conditions, providing the business with high macro resilience.

sperotherapeutics.com (SPRO): Net earnings per share growth this year from 07/04/2022 to 11/14/2026

Analytical breakdowns and data insights for company Spero Therapeutics (SPRO)

- current price and projected stock value:
Quote Chart Spero Therapeutics Inc|SPRO - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Spero Pharma|SPRO - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Spero Therapeutics|SPRO - Company Net Assets|Market Cap to Book Value Multiple sperotherapeutics.com|SPRO - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Spero Therapeutics|SPRO - Long-Term Debt to Equity|Current Liabilities to Capital sperotherapeutics.com|SPRO - Company Debts|Debt to Book Value Ratio Spero Pharma|SPRO - Company Long-Term Debt|Short-Term Debt Volume Spero Therapeutics|Interim Coverage Ratio sperotherapeutics.com
- net income and valuation ratios data:
SPRO - Company Net Income|Forward Earnings Spero Therapeutics|SPRO - P/E Multiple|Projected Price to Earnings Ratio Spero Pharma|SPRO - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Spero Pharma|SPRO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Spero Therapeutics|SPRO - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months sperotherapeutics.com|SPRO - Net earnings per share growth this year|Projected earnings per share increase next year Spero Therapeutics
- company sales and revenue statistics:
SPRO - Revenue and Sales Volume|Company Future Revenue Spero Therapeutics Inc|SPRO - P/S Multiple|Market Cap to Future Revenue Ratio Spero Pharma
Basic company analysis:Spero Therapeutics Inc
Mass-produced product of Spero

Earnings per share dynamics reflect the year-over-year growth rates of the business's net profitability. By analyzing the final annual EPS growth figure, an investor can see the percentage deviation of the current value from the same period last year. The current value of -721.10 allows for an assessment of asset capitalization efficiency. For Spero Therapeutics (SPRO), this metric is indicative when evaluating the commercialization of new antibiotics. Strategic partnerships formed by management help stabilize this figure by sharing operational risks.

Main competitors

Earnings per share trend in current year SMMT (Summit Therapeutics plc)|MRNA (Moderna Corp) - Earnings growth in current year|Earnings per share growth rate in current year SutroVax PCVX|Earnings growth in current year TARS|Net earnings per share growth this year cormedix.com CRMD|Seres Therapeutics, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year SCYX (SCYNEXIS Inc)|AN2 Bio - Earnings growth in current year|Expected net earnings per share growth this year PolyPid Ltd. PYPD|LakeShore Biopharma Co. (LSB) - Earnings per share growth in current year|Earnings per share growth rate in current year Iterum Therapeutics (ITRM)|Earnings per share growth in current year BiomX Inc|Earnings per share growth this year SNGX (BioPharma Bio)|Earnings per share growth in current year 60 Degrees Pharmaceuticals (SXTP)|Expected net earnings per share growth this year oragenics.com|Earnings per share growth in current year OpGen, Inc. OPGN